Icici Prudential Nifty Pharma Index Fund Datagrid
Category Index Fund
BMSMONEY Rank 4
Rating
Growth Option 24-07-2026
NAV ₹19.34(R) -0.37% ₹19.79(D) -0.37%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 12.88% 20.49% -% -% -%
Direct 13.6% 21.25% -% -% -%
Benchmark
SIP (XIRR) Regular 23.04% 15.57% -% -% -%
Direct 23.83% 16.29% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.94 0.49 0.88 -% -
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.64% -19.17% -15.25% - 11.92%
Fund AUM As on: 30/12/2025 92 Cr
Top Index Fund
Fund Name Rank Rating
Motilal Oswal S&P 500 Index Fund 1
ICICI PRUDENTIAL NASDAQ 100 INDEX FUND 2
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund 3
ICICI Prudential Nifty Pharma Index Fund 4
UTI NIFTY 500 Value 50 Index Fund 5
Navi Nifty India Manufacturing Index Fund 6
ICICI Prudential Nifty Auto Index Fund 7
AXIS Nifty Midcap 50 Index Fund 8
SBI NIFTY MIDCAP 150 INDEX FUND 9
Axis CRISIL IBX SDL May 2027 Index Fund 10
Nippon India Nifty Midcap 150 Index Fund 11
Aditya Birla Sun Life Nifty Midcap 150 Index Fund 12
Motilal Oswal Nifty Midcap 150 Index Fund 13
HDFC Nifty Midcap 150 Index Fund 14
Mirae Asset Nifty SDL Jun 2027 Index Fund 15
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund 16
Kotak Nifty SDL Apr 2027 Top 12 Eq Wt Index Fund 17
Nippon India Nifty AAA CPSE Bond Plus SDL - Apr 2027 Maturity 60:40 Index Fund 18
ICICI Prudential Nifty Midcap 150 Index Fund 19
Aditya Birla Sun Life CRISIL IBX 60:40 SDL + AAA PSU - Apr 2027 Index Fund 20
Axis Nifty Smallcap 50 Index Fund 21
Aditya Birla Sun Life Nifty SDL Plus PSU Bond Sep 2026 60:40 Index Fund 22
ICICI Prudential Nifty SDL Sep 2027 Index Fund 23

NAV Date: 24-07-2026

Scheme Name NAV Rupee Change Percent Change
ICICI Prudential Nifty Pharma Index Fund - IDCW 19.34
-0.0700
-0.3700%
ICICI Prudential Nifty Pharma Index Fund - Growth 19.34
-0.0700
-0.3700%
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - IDCW 19.79
-0.0700
-0.3700%
ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth 19.79
-0.0700
-0.3700%

Review Date: 24-07-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.22
-0.46
-4.55 | 7.03 19 | 274 Very Good
3M Return % 13.14
2.23
-12.43 | 14.14 4 | 265 Very Good
6M Return % 17.19
2.08
-25.31 | 22.25 7 | 254 Very Good
1Y Return % 12.88
0.38
-24.71 | 34.53 14 | 233 Very Good
3Y Return % 20.49
11.78
-0.21 | 28.43 7 | 112 Very Good
1Y SIP Return % 23.04
1.84
-25.26 | 29.58 6 | 228 Very Good
3Y SIP Return % 15.57
6.11
-11.80 | 27.37 3 | 108 Very Good
Standard Deviation 16.64
14.64
0.55 | 22.91 62 | 110 Average
Semi Deviation 11.92
10.77
0.37 | 17.17 60 | 110 Average
Max Drawdown % -15.25
-17.10
-37.89 | 0.00 38 | 110 Good
VaR 1 Y % -19.17
-22.25
-38.54 | 0.00 24 | 110 Very Good
Average Drawdown % 6.56
7.28
0.00 | 14.99 68 | 110 Average
Sharpe Ratio 0.94
0.56
-0.34 | 2.15 20 | 110 Very Good
Sterling Ratio 0.88
0.49
-0.05 | 1.48 4 | 110 Very Good
Sortino Ratio 0.49
0.33
-0.09 | 1.81 20 | 110 Very Good
Return data last Updated On : July 24, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.27 -0.43 -4.51 | 7.07 19 | 285 Very Good
3M Return % 13.33 2.36 -12.33 | 14.29 3 | 276 Very Good
6M Return % 17.57 2.37 -25.07 | 22.62 7 | 263 Very Good
1Y Return % 13.60 0.91 -24.29 | 35.19 14 | 235 Very Good
3Y Return % 21.25 12.30 0.46 | 29.02 7 | 112 Very Good
1Y SIP Return % 23.83 2.27 -24.86 | 30.22 6 | 230 Very Good
3Y SIP Return % 16.29 6.54 -11.15 | 27.98 3 | 108 Very Good
Standard Deviation 16.64 14.64 0.55 | 22.91 62 | 110 Average
Semi Deviation 11.92 10.77 0.37 | 17.17 60 | 110 Average
Max Drawdown % -15.25 -17.10 -37.89 | 0.00 38 | 110 Good
VaR 1 Y % -19.17 -22.25 -38.54 | 0.00 24 | 110 Very Good
Average Drawdown % 6.56 7.28 0.00 | 14.99 68 | 110 Average
Sharpe Ratio 0.94 0.56 -0.34 | 2.15 20 | 110 Very Good
Sterling Ratio 0.88 0.49 -0.05 | 1.48 4 | 110 Very Good
Sortino Ratio 0.49 0.33 -0.09 | 1.81 20 | 110 Very Good
Return data last Updated On : July 24, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Icici Prudential Nifty Pharma Index Fund NAV Regular Growth Icici Prudential Nifty Pharma Index Fund NAV Direct Growth
24-07-2026 19.339 19.7881
23-07-2026 19.4111 19.8614
22-07-2026 19.486 19.9377
21-07-2026 19.7423 20.1996
20-07-2026 19.6754 20.1308
17-07-2026 19.4067 19.8548
16-07-2026 19.672 20.1258
15-07-2026 19.6709 20.1243
14-07-2026 19.5984 20.0498
13-07-2026 19.4 19.8464
10-07-2026 19.425 19.8709
09-07-2026 19.402 19.847
08-07-2026 19.2321 19.6729
07-07-2026 19.4205 19.8652
06-07-2026 19.5525 19.9998
03-07-2026 19.4627 19.9069
02-07-2026 19.1346 19.571
01-07-2026 19.0402 19.474
30-06-2026 19.1489 19.5848
29-06-2026 19.075 19.5089
25-06-2026 18.8817 19.3099
24-06-2026 18.9196 19.3482

Fund Launch Date: 14/Dec/2022
Fund Category: Index Fund
Investment Objective: The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.
Fund Description: An open ended Index scheme replicating Nifty Pharma Index
Fund Benchmark: Nifty Pharma TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.